Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells

Journal of Cellular Biochemistry

Volumn 108, Issue 1, 2009, Pages 295-303

  Bi, Yang ^a,b   Huang, Jiayi ^a,b   He, Yun ^a,b   Zhu, Gao Hui ^a,b   Su, Yuxi ^a,b   He, Bai Cheng ^a,b   Luo, Jinyong ^a,b   Wang, Yi ^a,b   Kang, Quan ^a,b   Luo, Qing ^a,b   Chen, Liang ^a,b   Zuo, Guo Wei ^a,b   Jiang, Wei ^b   Liu, Bo ^a,b   Shi, Qiong ^a,b   Tang, Min ^a,b   Zhang, Bing Qiang ^a,b   Weng, Yaguang ^a   Huang, Ailong ^a   Zhou, Lan ^a,b   Feng, Tao ^a,b   Luu, Hue H ^b   Haydon, Rex C ^b   He, Tong Chuan ^a,b   Tang, Ni ^a,b   more..

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Hepatic differentiation; Hepatic progenitor cells; Liver regeneration; SFRP3; SFRPs; Wnt catenin signaling

Indexed keywords

ALBUMIN; DEXAMETHASONE; DICKKOPF 2 PROTEIN; FRIZZLED PROTEIN; GLYCOPROTEIN; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 3; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GENE; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; LIVER REGENERATION; LIVER STEM CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; WNT GENE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; FEMALE; GLYCOPROTEINS; HEPATOCYTES; HUMANS; LIVER; MICE; STEM CELLS; WNT PROTEINS;

EID: 69249098540     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22254     Document Type: Article

References (42)

1. Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP. 2006. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44:992-1002.
2. Apte U, Zeng G, Thompson MD, Muller P, Micsenyi A, Cieply B, Kaestner KH, Monga SP. 2007. beta-Catenin is critical for early postnatal liver growth. Am J Physiol Gastrointest Liver Physiol 292:G1578-G1585.
3. Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, Kuo CJ, Kahn A, Perret C, Colnot S. 2006. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 10:759-770.
4. Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C. 2001. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res 61:3245-3249.
5. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A:1544-1552.
6. Clevers H. 2006. Wnt/beta-catenin signaling in development and disease. Cell 127:469-480.
7. Fausto N, Campbell JS. 2003. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120:117-130.
8. Grigoryan T, Wend P, Klaus A, Birchmeier W. 2008. Deciphering the function of canonical Wnt signals in development and disease: Conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev 22:2308-2341.
9. Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo MM. 2002. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Cancer Res 62:1971-1977.
10. Hay DC, Fletcher J, Payne C, Terrace JD, Gallagher RC, Snoeys J, Black JR, Wojtacha D, Samuel K, Hannoun Z, Pryde A, Filippi C, Currie IS, Forbes SJ, Ross JA, Newsome PN, Iredale JP. 2008. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci USA 105:12301-12306.
11. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998a. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
12. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. 1998b. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509-2514.
13. He TC, Chan TA, Vogelstein B, Kinzler KW. 1999. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345.
14. Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG. 2007. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 133:1579-1591.
15. Jiang F, Parsons CJ, Stefanovic B. 2006. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol 45:401-409.
16. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He TC. 2004. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11:1312-1320.
17. Luo Q, Kang Q, Si W, Jiang W, Park JK, Peng Y, Li X, Luu HH, Luo J, Montag AG, Haydon RC, He TC. 2004. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279:55958-55968.
18. Luo J, Chen J, Deng ZL, Luo X, Song WX, Sharff KA, Tang N, Haydon RC, Luu HH, He TC. 2007a. Wnt signaling and human diseases: What are the therapeutic implications? Lab Invest 87:97-103.
19. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, Vogelstein B, He TC. 2007b. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2:1236-1247.
20. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, He TC. 2004. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 4:653-671.
21. Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK, Monga SP. 2004. Beta-catenin is temporally regulated during normal liver development. Gastroenterology 126:1134-1146.
22. Miller JR. 2002. The Wnts. Genome Biol 3(1): 1465-6914 (Electronic).
23. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. 2001. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 33:1098-1109.
24. Oertel M, Shafritz DA. 2008. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 1782:61-74.
25. Peng Y, Kang Q, Cheng H, Li X, Sun MH, Jiang W, Luu HH, Park JY, Haydon RC, He TC. 2003. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 90:1149-1165.
26. Schmelzer E, Wauthier E, Reid LM. 2006. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 24:1852-1858.
27. Sekine S, Gutierrez PJ, Lan BY, Feng S, Hebrok M. 2007. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology 45:361-368.
28. Sell S. 2001. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 33:738-750.
29. Sharff KA, Song WX, Luo X, Tang N, Luo J, Chen J, Bi Y, He BC, Huang J, Li X, Jiang W, Zhu GH, Su Y, He Y, Shen J, Wang Y, Chen L, Zuo GW, Liu B, Pan X, Reid RR, Luu HH, Haydon RC, He TC. 2009. Hey1 basic helix-loop-helix (bHLH) protein plays an important role in mediating BMP9 induced osteogenic differentiation of mesenchymal progenitor cells. J Biol Chem 284:649-659.
30. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC. 2006. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26:2955-2964.
31. Strick-Marchand H, Weiss MC. 2002. Inducible differentiation and morphogenesis of bipotential liver cell lines from wild-type mouse embryos. Hepatology 36:794-804.
32. Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, Monga DK, Bell A, Michalopoulos GK, Monga SP. 2005. Epidermal growth factor receptor: A novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 129:285-302.
33. Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. 2006. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 131:1561-1572.
34. Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, Stolz DB, Michalopoulos GK, Kaestner KH, Monga SP. 2008. Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. Hepatology 47:1667-1679.
35. Tang N, Song WX, Luo J, Luo X, Chen J, Sharff KA, Bi Y, He BC, Huang JY, Zhu GH, Su YX, Jiang W, Tang M, He Y, Wang Y, Chen L, Zuo GW, Shen J, Pan X, Reid RR, Luu HH, Haydon RC, He TC. 2008. BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/b-catenin signaling. J Cell Mol Med [Epub ahead of print].
36. Thompson MD, Monga SP. 2007. WNT/beta-catenin signaling in liver health and disease. Hepatology 45:1298-1305.
37. Walkup MH, Gerber DA. 2006. Hepatic stem cells: In search of. Stem Cells 24:1833-1840.
38. Westerman KA, Leboulch P. 1996. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci USA 93:8971-8976.
39. Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
40. Zaret KS. 2008. Genetic programming of liver and pancreas progenitors: Lessons for stem-cell differentiation. Nat Rev Genet 9:329-340.
41. Zaret KS, Grompe M. 2008. Generation and regeneration of cells of the liver and pancreas. Science 322:1490-1494.
42. Zeng G, Awan F, Otruba W, Muller P, Apte U, Tan X, Gandhi C, Demetris AJ, Monga SP. 2007. Wnt'er in liver: Expression of Wnt and frizzled genes in mouse. Hepatology 45:195-204.